Platelet is the early predictor of bronchopulmonary dysplasia in very premature infants: an observational cohort study

被引:7
|
作者
Wang, Xiaoling [1 ,2 ]
Ma, Yan [1 ,2 ]
Wang, Shenghui [1 ,2 ]
Dong, Wenbin [1 ,2 ]
Lei, Xiaoping [1 ,2 ]
机构
[1] Southwest Med Univ, Affiliated Hosp, Dept Pediat, Div Neonatol, 8,Sect 2,Kangcheng Rd, Luzhou 646000, Peoples R China
[2] Sichuan Clin Res Ctr Birth Defects, 8,Sect 2,Kangcheng Rd, Luzhou 646000, Peoples R China
关键词
Bronchopulmonary dysplasia; Platelet parameters; Premature infant; Thrombocytopenia; PRETERM; LUNG; THROMBOCYTOPENIA; TRANSFUSION; MORTALITY; CHILDREN; VOLUME; RISK;
D O I
10.1186/s12890-022-01895-2
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background A previous study showed that the lungs are involved in the biogenesis of platelets (PLTs). Thus, the present study aimed to investigate the association between bronchopulmonary dysplasia (BPD), a chronic lung disease, and PLT parameters in very premature infants. Methods The study subjects were premature infants with a gestational age of <= 30 weeks and birth weight of <= 1500 g in a preterm birth cohort study recruited between January 1, 2015, and August 31, 2019. BPD was defined as the need for oxygen supplementation more than 28 days after birth. The PLT count, mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT) level were compared between BPD and non-BPD infants. A generalized estimating equation model was used to adjust for confounding factors. A forward stepwise logistic regression model was used to calculate the adjusted odds ratio (OR) for thrombocytopenia in the BPD group. Receiver operating characteristic curve analysis was performed to assess the predictive value of PLT count combined with gestational age (GA) and birth weight (BW) for BPD. Results The final study subjects were 134 very premature infants, namely, 64 infants with BPD and 70 infants without BPD. The BPD infants had lower PLT counts (F = 4.44, P = 0.03) and PCT levels (F = 12.54, P = 0.00) than the non-BPD infants. However, the MPV (F = 14.25, P = 0.00) and PDW (F = 15.04, P = 0.00) were higher in the BPD group. After adjusting for potential confounding factors, the BPD infants had a higher risk of thrombocytopenia than the non-BPD infants (adjusted aOR 2.88, 95% CI 1.01-8.15), and the risk of BPD was increased in very premature infants with a PLT count <= 177*10(9)/L (OR 4.74, 95% CI 1.93-11.62) at the end of the second week. In the multivariate predictive model, it was showed that the AUC area (0.85), sensitivity (0.88), specificity (0.70) and Youden index (0.58) are improved using PLT counts <= 177*10(9)/L combined with GA and BW. Conclusions Abnormal PLT parameters were observed in BPD infants, and a PLT count <= 177*10(9)/L was a potential risk factor for the development of BPD in very premature infants.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Serum selenium levels of the very low birth weight premature newborn infants with bronchopulmonary dysplasia
    Peirovifar, Ali
    Gharehbaghi, Manizheh Mostafa
    Abdulmohammad-zadeh, Hossein
    Sadegi, Gholam Hossein
    Jouyban, Abulghasem
    [J]. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2013, 27 (04) : 317 - 321
  • [32] Growth and development in premature infants with bronchopulmonary dysplasia (BPD)
    Alshaar, M.
    Sajous, C.
    Weiss, M.
    [J]. PEDIATRIC RESEARCH, 2007, 62 (04) : 520 - 520
  • [33] Lung Ultrasonography to Diagnose Bronchopulmonary Dysplasia of Premature Infants
    Liu, Jing
    Chi, Jing-Han
    Fu, Wei
    Zhang, Li
    Qiu, Ru-Xin
    [J]. IRANIAN JOURNAL OF PEDIATRICS, 2021, 31 (04)
  • [34] The association of γδ-T cells with bronchopulmonary dysplasia in premature infants
    Wang, Yin-juan
    Zhang, Xiao-li
    Liu, Jia-xin
    Niu, Ming
    Jin, Xin-yun
    Yuan, En-wu
    Shi, Ying
    Li, Wen-li
    Xu, Fa-lin
    [J]. HUMAN IMMUNOLOGY, 2021, 82 (01) : 54 - 59
  • [35] Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants
    Jessica Balena-Borneman
    Namasivayam Ambalavanan
    Hemant K. Tiwari
    Russell L. Griffin
    Brian Halloran
    David Askenazi
    [J]. Pediatric Research, 2017, 81 : 519 - 525
  • [36] Biomarkers associated with bronchopulmonary dysplasia/mortality in premature infants
    Balena-Borneman, Jessica
    Ambalavanan, Namasivayam
    Tiwari, Hemant K.
    Griffin, Russell L.
    Halloran, Brian
    Askenazi, David
    [J]. PEDIATRIC RESEARCH, 2017, 81 (03) : 519 - 525
  • [37] Furosemide Exposure and Prevention of Bronchopulmonary Dysplasia in Premature Infants
    Greenberg, Rachel G.
    Gayam, Sreepriya
    Savage, Destiny
    Tong, Andrew
    Gorham, Daniel
    Sholomon, Ari
    Clark, Reese H.
    Benjamin, Daniel K.
    Laughon, Matthew
    Smith, P. Brian
    [J]. JOURNAL OF PEDIATRICS, 2019, 208 : 134 - +
  • [38] A nomogram for predicting the risk of Bronchopulmonary dysplasia in premature infants
    Shen, Xian
    Patel, Nishant
    Zhu, Wen
    Chen, Xu
    Lu, Keyu
    Cheng, Rui
    Mo, Xuming
    [J]. HELIYON, 2023, 9 (08)
  • [39] Comparisons of two definitions of bronchopulmonary dysplasia for the premature infants
    Li, Jiahui
    Xu, Haiyan
    [J]. PEDIATRIC PULMONOLOGY, 2022, 57 (01) : 217 - 223
  • [40] Serum enzyme activities in premature infants with bronchopulmonary dysplasia
    Zanardo, V
    Rizzo, L
    Trevisanuto, D
    Simbi, KA
    Golin, R
    Magarotto, M
    Marzari, F
    [J]. FETAL DIAGNOSIS AND THERAPY, 1999, 14 (06) : 341 - 344